재발률 낮춘 레미브루티닙, 3상 2건서 테리플루노마이드와 비교
Open the sourceReported by TokenPost, tokenpost.kr, 30 October 2026, by 이도현
50
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at tokenpost.kr.